EcoR1 Capital Investor
EcoR1 Capital is an investment advisory firm focused on the biotech industry. They aim to identify and evaluate innovative therapeutic solutions that can bring significant improvements to patients' lives. Drawing inspiration from the transformative power of the EcoR1 restriction enzyme in the biomedical field, they invest in biotech companies that offer promising new treatments for untreated diseases. EcoR1 Capital recognizes the importance of building upon the innovative contributions of its predecessors in order to continue advancing medical research.
Technology:
Biopharma & Life Science Tools
Number Of Exists:
89
Investor Type:
Angel Investors
Employee Number:
11-50
Headquarters:
San Francisco, California, United States
Founded Date:
2012
Country:
United States
City:
San Francisco
Founders:
Oleg Nodelman
Investment Rounds:
139
Exits:
89